CoreWeave Stock (CRWV) Gains New Bull as Roth Capital Initiates at $110

CoreWeave's stock (NASDAQ: CRWV) has received a new vote of confidence as Roth Capital initiated coverage with a “Buy” rating and a price target of $110, expecting significant growth from the firm in the burgeoning AI cloud market. The stock, currently trading at $86.22 in the pre-market, has experienced a recent 13% surge on the week, reflecting renewed investor optimism after a pullback.

The analyst firm's bullish stance hinges on CoreWeave's potential to capture a leading market share in the AI cloud sector, which they predict could surpass the traditional internet cloud in size. Roth Capital cites CoreWeave's “proven scale,” rapid market entry, and superior product-price performance compared to both specialized AI cloud providers and established hyperscalers. The firm also notes the attractive risk-reward profile, given the stock's approximately 40% decline since early October.

This positive analyst coverage comes amidst a series of significant developments for CoreWeave. In late September 2025, the company announced a massive $14.2 billion agreement with Meta Platforms (NASDAQ: META) to supply Nvidia's cutting-edge GB300 systems. This deal underscores the increasing demand for AI infrastructure and solidifies CoreWeave's position as a key player in the market.

However, the company faced some headwinds as well. On November 10, CoreWeave reported third-quarter revenues of $1.36 billion, exceeding analyst expectations. Despite the strong quarterly performance, CoreWeave revised its full-year revenue guidance downward to $5.05–$5.15 billion, attributing the adjustment to delays at a third-party data center partner.

Strategically, CoreWeave has been active in expanding its capabilities. In late October, the company acquired Marimo, the creator of an open-source AI-native Python development environment. This acquisition is designed to enhance CoreWeave's AI development capabilities and streamline workflows for developers, potentially attracting more users to its platform.

Adding to the complexity, a proposed $9 billion all-stock merger with Core Scientific was rejected by Core Scientific shareholders on October 30, 2025. The failure of this merger, which aimed to significantly expand CoreWeave's data center infrastructure, introduced uncertainties regarding the company's growth strategy and its ability to meet future demand.

Despite recent operational challenges and a failed merger, strong analyst sentiment, including the new “Buy” rating from Roth Capital and bullish targets from Cantor Fitzgerald and H.C. Wainwright, underscores confidence in CoreWeave's long-term prospects.